Diagram showing some of the factors that mediate cytokin storm following infection with COVID-19. by Joseph Rabin (7399436)

Subjects:

Antibodies used for flow cytometry experiments. by Joseph Rabin (7399436)

Subjects:

Changes of plasma proinflammatory cytokines/chemokines during and after RA infusion. by Joseph Rabin (7399436)

Subjects:

Demographics of the COVID-19 patients who received regadenoson treatment. by Joseph Rabin (7399436)

Subjects:

Subject flow diagram. by Joseph Rabin (7399436)

Subjects:

Effects of regadenoson (RA) infusion on oxygen saturation and C-reactive protein (CRP) levels in plasma of COVID-19 patients. by Joseph Rabin (7399436)

Subjects:

<b>Diroximel fumarate acts through Nrf2 to attenuate methylglyoxal-induced nociception in mice and decrease ISR activation in DRG neurons</b> by Muhammad Saad Yousuf (20745168)

Summary of findings table for the comparison of remdesivir 5 days vs. remdesivir 10 days for hospitalized, severe COVID-19. by Alejandro Piscoya (782326)

Klf5 expression is down-regulated in the ruptured human and experimental AAA. by Dong Ma (584680)

Subjects:

Dose- and time-dependent effect of IL-13, IL-4, and TGF-β1 on benzamil-sensitive <i>I</i>_sc and TEER in HBECs. by Anusree Sasidharan (19226521)

Simultaneously inhibition <i>Nlu-miR-34</i> and <i>NlInR2</i> in SW strain induced the decrease of SW BPHs. by Xinhai Ye (6857771)

“…<p>(A) Antagomir-34 (with two different quantities) and ds<i>NlInR2</i> (0.84 ng) were injected into the third instar SW strain nymphs, showed that injection of antagomir-34 decreased the ratio of SW type BPH (Chi-square test, 40ng: χ² = 5.8, df = 1, <i>p</i> = 0.003; 60ng: χ² = 7.9, df = 1, <i>p</i> = 0.042). …”

The U937 cell line was seeded at 2 x 10⁵ cells per well. by Janani Madhuravasal Krishnan (19736002)

The U937 cell line was seeded at 1 x 10⁵ cells per well. by Janani Madhuravasal Krishnan (19736002)

The U937 cell line was seeded at 2 x 10⁵ cells per well. by Janani Madhuravasal Krishnan (19736002)

Flowchart of study selection. by Alejandro Piscoya (782326)

Description of characteristics of included studies. by Alejandro Piscoya (782326)

Effect of remdesivir on invasive ventilation at 14 days. by Alejandro Piscoya (782326)

Effect of remdesivir on all-cause mortality at 14 days. by Alejandro Piscoya (782326)

Summary of findings table for the comparison remdesivir 5 days vs. standard of care for hospitalized, moderate COVID-19. by Alejandro Piscoya (782326)

PK profiles of paeoniflorin and paeonol comparing low and high repeated doses of MC in DNBS-induced colitis rats. by Jin-Hwa Kim (101817)

Subjects: